<?xml version="1.0" encoding="UTF-8"?>
<project>
  <language>en</language>
  <availableLanguages readOnly="true">en</availableLanguages>
  <rcn>252999</rcn>
  <id>101114473</id>
  <acronym>RespirOndine</acronym>
  <teaser>AtmosR is a start-up whose mission is to develop innovative therapeutic solutions for patients suffering from severe and often fatal disorders of the central nervous system.Our company has established a technology in order to develop treatments for aggregate pathologies (such...</teaser>
  <objective>AtmosR is a start-up whose mission is to develop innovative therapeutic solutions for patients suffering from severe and often fatal disorders of the central nervous system.

Our company has established a technology in order to develop treatments for aggregate pathologies (such as ALS, Kennedy disease, Multisystem Atrophy, Parkinson, Huntington...) which represent a major health problem considering the high number of patients worldwide and the high unmet medical need. 

The first disorder targeted by AtmosR is Congenital Central Hypoventilation Syndrome (CCHS), a rare genetic syndrome which presents as its main symptom severe periods of hypoventilation. Patients are kept alive thanks to mechanical ventilation administered through a tracheostomy. Our goal is to develop a drug that will be life changing for patients and their families, liberating them from the machine, lifting the vital risk and allowing them to live independently.

Our team consists of multidisciplinary profiles with experience in both drug development, particularly in the field of rare diseases, and in business management. As a spin-off of the french CCHS patient organization, we work in close cooperation with the international academic experts in CCHS, especially in France, Italy and Israël. 

We have identified a Hit compound ATS-003 that is active in both in vitro and in vivo CCHS robust models and we have optimized the compound thanks to a chemistry program in order to improve its efficiency and lower its toxicity for a better long term use tolerance. We are starting regulatory preclinical work in 2023 with this new Lead compound and have planned the first clinical trials by mid 2025 and an early drug access for patients in 2027.

In addition to CCHS, we have identified  several disorders with similar protein aggregation mechanisms. We plan to test and develop our Lead compound for other more common disorders and the purpose of this project is to idententify the most promising one for our Lead.</objective>
  <title>Development of life changing drugs for patients suffering from severe and fatal neurological disorders</title>
  <keywords>neurological, disorder, drug, treatment, innovation, life changing, transformativ</keywords>
  <totalCost>0</totalCost>
  <ecMaxContribution>75000</ecMaxContribution>
  <startDate>2023-07-01</startDate>
  <endDate>2023-12-31</endDate>
  <ecSignatureDate>2023-06-01</ecSignatureDate>
  <duration>6</duration>
  <status>CLOSED</status>
  <identifiers>
    <grantDoi>10.3030/101114473</grantDoi>
  </identifiers>
  <validation>
    <euroSciVoc>false</euroSciVoc>
  </validation>
  <sourceUpdateDate>2023-06-05 21:54:34</sourceUpdateDate>
  <contentCreationDate readOnly="true">2023-07-11 15:43:39</contentCreationDate>
  <contentUpdateDate>2023-07-11 15:43:31</contentUpdateDate>
  <lastUpdateDate readOnly="true">2025-11-03 09:43:59</lastUpdateDate>
  <relations>
    <associations>
      <article source="editorial" type="relatedArticle">
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <rcn>445848</rcn>
        <id>445848-life-changing-drug-development-for-neurological-disorders</id>
        <title>Life-changing drug development for neurological disorders</title>
        <contentUpdateDate>2023-12-28 15:50:27</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/projectDescription</code>
              <title>Project description</title>
              <description>Article: description of linked project written by editorial team</description>
              <displayCode readOnly="true">/Project description</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/editorial</code>
              <title>CORDIS Editorial</title>
              <description>Written by CORDIS</description>
              <displayCode readOnly="true">/CORDIS Editorial</displayCode>
            </category>
          </categories>
        </relations>
      </article>
      <call source="corda" type="relatedMasterCall">
        <rcn>55653</rcn>
        <title>HORIZON-EIE-2022-SCALEUP-02</title>
        <identifier>HORIZON-EIE-2022-SCALEUP-02</identifier>
      </call>
      <call source="corda" type="relatedSubCall">
        <rcn>55653</rcn>
        <title>HORIZON-EIE-2022-SCALEUP-02</title>
        <identifier>HORIZON-EIE-2022-SCALEUP-02</identifier>
      </call>
      <organization source="corda" order="1" ecContribution="75000" terminated="false" sme="true" netEcContribution="75000" totalCost="0" type="coordinator">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>1982151</rcn>
        <id>885997904</id>
        <vatNumber>FR68852793108</vatNumber>
        <legalName>ATMOSR</legalName>
        <address>
          <street>10 IMPASSE DES LOTIERS</street>
          <city>Fuveau</city>
          <postalCode>13710</postalCode>
          <country>FR</country>
          <geolocation>49.3668878,6.1093699</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/PRC</code>
              <title>Private for-profit entities (excluding Higher or Secondary Education Establishments)</title>
              <displayCode readOnly="true">/Private for-profit entities (excluding Higher or Secondary Education Establishments)</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <name>Bouches-du-Rhône</name>
              <rcn>1464091</rcn>
              <nutsCode>FRL04</nutsCode>
              <parents>
                <region>
                  <name>Provence-Alpes-Côte d’Azur</name>
                  <rcn>1464968</rcn>
                  <nutsCode>FRL0</nutsCode>
                  <parents>
                    <region>
                      <name>Provence-Alpes-Côte d’Azur</name>
                      <rcn>1464967</rcn>
                      <nutsCode>FRL</nutsCode>
                      <parents>
                        <region>
                          <name>France</name>
                          <rcn>258902568</rcn>
                          <nutsCode>FR</nutsCode>
                          <euCode>FR</euCode>
                          <isoCode>FR</isoCode>
                        </region>
                      </parents>
                    </region>
                  </parents>
                </region>
              </parents>
            </region>
            <region type="relatedRegion">
              <name>France</name>
              <rcn>258902568</rcn>
              <nutsCode>FR</nutsCode>
              <euCode>FR</euCode>
              <isoCode>FR</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <programme source="corda" type="relatedTopic">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>706827</rcn>
        <id>HORIZON_HORIZON-EIE-2022-SCALEUP-02-02</id>
        <code>HORIZON-EIE-2022-SCALEUP-02-02</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <title>Women TechEU</title>
        <parent>
          <programme>
            <rcn>20300</rcn>
            <code>HORIZON-Topics</code>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/topic</code>
              <title>Topic</title>
              <description>Programme: Part of the Commission work programme implementing legal basis</description>
              <displayCode readOnly="true">/Topic</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43454413</code>
              <title>Materials engineering</title>
              <displayCode readOnly="true">/Materials engineering</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43449921</code>
              <title>Biotechnology</title>
              <displayCode readOnly="true">/Biotechnology</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43451548</code>
              <title>Energy</title>
              <displayCode readOnly="true">/Energy</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/42590846</code>
              <title>Innovation in the Culture and Audiovisual sectors</title>
              <displayCode readOnly="true">/Innovation in the Culture and Audiovisual sectors</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43452136</code>
              <title>Fintech (Financial technology)</title>
              <displayCode readOnly="true">/Fintech (Financial technology)</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43452211</code>
              <title>Food and beverages</title>
              <displayCode readOnly="true">/Food and beverages</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/31101542</code>
              <title>Education</title>
              <displayCode readOnly="true">/Education</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43450173</code>
              <title>Chemical engineering</title>
              <displayCode readOnly="true">/Chemical engineering</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43453531</code>
              <title>Information and Communication Technology (ICT)</title>
              <displayCode readOnly="true">/Information and Communication Technology (ICT)</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/31101546</code>
              <title>Engineering</title>
              <displayCode readOnly="true">/Engineering</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43451193</code>
              <title>Earth and related environmental sciences</title>
              <displayCode readOnly="true">/Earth and related environmental sciences</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/31101580</code>
              <title>Health</title>
              <displayCode readOnly="true">/Health</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43454761</code>
              <title>Mobility and transportation</title>
              <displayCode readOnly="true">/Mobility and transportation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43451374</code>
              <title>Electrical and electronic engineering</title>
              <displayCode readOnly="true">/Electrical and electronic engineering</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43449075</code>
              <title>Agriculture / Rural Development / Fisheries</title>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43450656</code>
              <title>Consumer products and services</title>
              <displayCode readOnly="true">/Consumer products and services</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <programme source="corda" uniqueProgrammePart="true" type="relatedLegalBasis">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>705796</rcn>
        <id>HORIZON.3.2</id>
        <code>HORIZON.3.2</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <pga>HORIZON.3.2</pga>
        <title>European innovation ecosystems</title>
        <parent>
          <programme>
            <rcn>705791</rcn>
            <code>HORIZON.3</code>
            <parent>
              <programme>
                <rcn>705725</rcn>
                <code>HORIZON</code>
              </programme>
            </parent>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/legalbasis</code>
              <title>Legal Basis</title>
              <description>Programme: Legal basis for research funding</description>
              <displayCode readOnly="true">/Legal Basis</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <result source="corda" type="relatedResult">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>1067035</rcn>
        <id>101114473_PSHORIZON</id>
        <title>Periodic Reporting for period 1 - RespirOndine (Development of life changing drugs for patients suffering from severe and fatal neurological disorders)</title>
        <teaser>AtmosR is a start-up whose mission is to develop innovative therapeutic solutions for patients suffering from severe of the central nervous system and currently without solution.Our company has established a technology to develop treatments for protein aggregation disorders...</teaser>
        <description>periodic</description>
        <sourceUpdateDate>2024-03-23 09:09:54</sourceUpdateDate>
        <contentUpdateDate>2024-03-26 14:16:00</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/pubsum</code>
              <title>Report Summary</title>
              <description>Result: Publishable summary (FP7 SESAM) and Summary for publication (H2020 SyGMa)</description>
              <displayCode readOnly="true">/Report Summary</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
          <associations>
            <webItem source="corda" type="relatedResultAttachment">
              <language>en</language>
              <availableLanguages readOnly="true">en,any</availableLanguages>
              <uri>/docs/results/horizon/101114/101114473_PS/photo-labo-atmosr.jpg</uri>
              <alternativeText>AtmosR team</alternativeText>
              <mimetype readOnly="true">image/jpeg</mimetype>
              <size readOnly="true">154624</size>
            </webItem>
          </associations>
        </relations>
      </result>
    </associations>
    <categories>
      <category classification="collection" type="belongsTo">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/project</code>
        <title>Project</title>
        <description>Project factsheets</description>
        <displayCode readOnly="true">/Project</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/23/49/327</code>
        <title>neurobiology</title>
        <displayCode readOnly="true">/natural sciences/biological sciences/neurobiology</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/21/35/159/79909316</code>
        <title>drug discovery</title>
        <displayCode readOnly="true">/medical and health sciences/basic medicine/pharmacology and pharmacy/drug discovery</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/21/35/145</code>
        <title>pathology</title>
        <displayCode readOnly="true">/medical and health sciences/basic medicine/pathology</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/21/35/153/627</code>
        <title>parkinson</title>
        <displayCode readOnly="true">/medical and health sciences/basic medicine/neurology/parkinson</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/29/91/523</code>
        <title>business and management</title>
        <displayCode readOnly="true">/social sciences/economics and business/business and management</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/digitalAgenda</code>
        <title>Digital agenda</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development of digital technologies and the digitisation of the economy and society (known as ‘Digital transition’).</description>
        <displayCode readOnly="true">/Digital agenda</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/cleanAir</code>
        <title>Clean air</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to the clean air policy (National Emission Ceiling Directive) aiming to improve ambient air quality and tackle air pollution, to protect the environment and human health.</description>
        <displayCode readOnly="true">/Clean air</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/ai</code>
        <title>Artificial intelligence</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development and deployment of AI-based technologies and solutions. Projects that develop AI-tools as part of their research method are included</description>
        <displayCode readOnly="true">/Artificial intelligence</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/climate</code>
        <title>Climate action</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to both mitigating climate change (e.g., contributions to the reduction of greenhouse gas emissions) and adapting to climate change by building resilience (e.g., regarding floods, droughts, spatial planning and better governance, adaptation to changing climate in value chains, etc.).</description>
        <displayCode readOnly="true">/Climate action</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/biodiversity</code>
        <title>Biodiversity</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to Europe’s biodiversity’s path to recovery including species protection, ecosystem conservation, and habitat rehabilitation, all essential for resilience in climate adaptation and addressing ecosystem services but also environmental crime and the health-environment connection.</description>
        <displayCode readOnly="true">/Biodiversity</displayCode>
      </category>
      <category classification="projectFundingSchemeCategory" type="relatedProjectFundingSchemeCategory">
        <language>en</language>
        <availableLanguages readOnly="true">en</availableLanguages>
        <code>/HORIZON-CSA</code>
        <title>HORIZON Coordination and Support Actions</title>
        <description>HORIZON Coordination and Support Actions</description>
        <displayCode readOnly="true">/HORIZON Coordination and Support Actions</displayCode>
      </category>
      <category classification="source" type="isProvidedBy">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/corda</code>
        <title>CORDA</title>
        <description>RTD research data warehouse</description>
        <displayCode readOnly="true">/CORDA</displayCode>
      </category>
    </categories>
  </relations>
</project>
